Tech Company Financing Transactions
Tempus Funding Round
On 3/17/2020, Tempus received $100 million in investment from Baillie Gifford, Franklin Templeton and New Enterprise Associates.
Transaction Overview
Company Name
Announced On
3/17/2020
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The latest fundraising will enhance our ability to forward-invest in new disease areas and geographies.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
600 West Chicago Ave. 510
Chicago, IL 60654
USA
Chicago, IL 60654
USA
Phone
Website
Email Address
Overview
Tempus is a technology company that is building the world's largest library of molecular and clinical data and an operating system to make that data accessible and useful.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Lefkofsky
Chief Financial Officer
Vanessa Rollings
Chief Operating Officer
Ryan Fukushima
Chief Scientific Officer
Joel Dudley
Chief Technical Officer
Shane Colley
Vice President
Nike Beaubier
Vice President
Martin Stumpe
VP - Bus. Development
Michael Yasiejko
VP - Bus. Development
Marc Yoskowitz
VP - General Counsel
Erik Phelps
VP - General Counsel
Lauren Silvis
VP - Human Resources
Colette Freeman
VP - Product Management
Eric Singley
Browse more venture capital transactions:
Prev: 3/17/2020: ZeroNorth venture capital transaction
Next: 3/18/2020: Circle Pharma venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs